Company Filing History:
Years Active: 1993
Title: Spotlight on Female Inventor Dana C. Matthews from Seattle, WA
Introduction:
Dana C. Matthews is a pioneering inventor hailing from Seattle, WA, who has made significant contributions to the field of radiation delivery to lymphoid and marrow tissues. With one patent to her name, Dana's work showcases a novel method for selectively delivering radiation to these tissues in vivo, emphasizing the importance of targeted treatment in medical advancements.
Latest Patents:
Dana C. Matthews' notable patent is titled "Radiation delivery to lymphoid and marrow tissues," which outlines a sophisticated approach to administering radiation homogeneously to specific tissues within the body. The patent highlights the use of radiolabeled immunological binding partners of a T-200 antigen to achieve effective doses, alongside innovative compositions for implementing this method.
Career Highlights:
Currently affiliated with the renowned Fred Hutchinson Cancer Research Center, Dana C. Matthews exemplifies dedication and expertise in the realm of cancer research and treatment. Her professional journey is marked by a commitment to pushing boundaries and exploring new avenues for improving radiation therapy techniques.
Collaborations:
In her endeavors, Dana C. Matthews has collaborated with esteemed colleagues such as Irwin D. Bernstein and John A. Hansen. These partnerships have led to synergistic research efforts, fostering a collaborative environment that thrives on collective knowledge and shared expertise in the fight against cancer and other diseases.
Conclusion:
In conclusion, Dana C. Matthews stands out as a trailblazing inventor in the realm of radiation delivery and targeted therapy. Her groundbreaking patent underscores the invaluable contributions she has made to medical science, highlighting the potential for novel approaches to treating lymphoid and marrow tissues. Dana's impactful work serves as a testament to the power of innovation and dedication in advancing healthcare solutions for the benefit of patients worldwide.